Gege Xu

4.5k total citations · 3 hit papers
59 papers, 3.3k citations indexed

About

Gege Xu is a scholar working on Molecular Biology, Spectroscopy and Oncology. According to data from OpenAlex, Gege Xu has authored 59 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 17 papers in Spectroscopy and 11 papers in Oncology. Recurrent topics in Gege Xu's work include Glycosylation and Glycoproteins Research (27 papers), Advanced Proteomics Techniques and Applications (14 papers) and Infant Nutrition and Health (7 papers). Gege Xu is often cited by papers focused on Glycosylation and Glycoproteins Research (27 papers), Advanced Proteomics Techniques and Applications (14 papers) and Infant Nutrition and Health (7 papers). Gege Xu collaborates with scholars based in United States, China and Thailand. Gege Xu's co-authors include Carlito B. Lebrilla, Elisha Goonatilleke, Andreas J. Bäumler, Franziska Faber, Erin E. Olsan, Mariana X. Byndloss, Christopher A. Lopez, Fabian Rivera-Chávez, Qiongyu Li and L. Renee Ruhaak and has published in prestigious journals such as Science, Chemical Reviews and Proceedings of the National Academy of Sciences.

In The Last Decade

Gege Xu

56 papers receiving 3.3k citations

Hit Papers

Microbiota-activated PPAR-γ signaling inhibits dysbiotic ... 2016 2026 2019 2022 2017 2016 2018 250 500 750

Peers

Gege Xu
Yan Ren China
David J. Gonzalez United States
Angela M. Zivkovic United States
Michael Wacker United States
Michael Affolter Switzerland
Jürgen Behr Germany
Yan Ren China
Gege Xu
Citations per year, relative to Gege Xu Gege Xu (= 1×) peers Yan Ren

Countries citing papers authored by Gege Xu

Since Specialization
Citations

This map shows the geographic impact of Gege Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gege Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gege Xu more than expected).

Fields of papers citing papers by Gege Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gege Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gege Xu. The network helps show where Gege Xu may publish in the future.

Co-authorship network of co-authors of Gege Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Gege Xu. A scholar is included among the top collaborators of Gege Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gege Xu. Gege Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Kai, Hyunwoo Kwon, Tomislav Čaval, et al.. (2024). Decoding the glycoproteome: a new frontier for biomarker discovery in cancer. Journal of Hematology & Oncology. 17(1). 12–12. 39 indexed citations
2.
Sun, Maomao, Yuying Li, Gege Xu, et al.. (2024). Sirt3-Mediated Opa1 Deacetylation Protects Against Sepsis-Induced Acute Lung Injury by Inhibiting Alveolar Macrophage Pro-Inflammatory Polarization. Antioxidants and Redox Signaling. 41(16-18). 1014–1030. 14 indexed citations
3.
Dhar, Chirag, Prasanna Ramachandran, Gege Xu, et al.. (2024). Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling. British Journal of Cancer. 130(10). 1716–1724. 5 indexed citations
4.
Xu, Gege, Rachel Rice, Yana G. Najjar, et al.. (2023). Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapy. Frontiers in Immunology. 14. 1187332–1187332. 9 indexed citations
5.
Park, Dayoung, Gege Xu, Simon Park, et al.. (2023). Combined analysis of secreted proteins and glycosylation identifies prognostic features in cholangiocarcinoma. Journal of Cellular Physiology. 239(3). e31147–e31147. 5 indexed citations
6.
Shah, Ankita, et al.. (2023). Use of glycoproteome profiles to detect advanced adenomas and colorectal cancer.. Journal of Clinical Oncology. 41(4_suppl). 69–69. 1 indexed citations
7.
Raposo, Ana Cláudia, Carlito B. Lebrilla, Ricardo Wagner Portela, Gege Xu, & Arianne Pontes Oriá. (2021). The glycoproteomics of hawk and caiman tears. BMC Veterinary Research. 17(1). 381–381.
8.
Maverakis, Emanual, Alexander A. Merleev, Dayoung Park, et al.. (2021). Glycan biomarkers of autoimmunity and bile acid-associated alterations of the human glycome: Primary biliary cirrhosis and primary sclerosing cholangitis-specific glycans. Clinical Immunology. 230. 108825–108825. 3 indexed citations
9.
Wu, Zhenqin, Daniel Serie, Gege Xu, & James Zou. (2020). PB-Net: Automatic peak integration by sequential deep learning for multiple reaction monitoring. Journal of Proteomics. 223. 103820–103820. 19 indexed citations
10.
Ehrlich, Amy M., Alline R. Pacheco, Bethany M. Henrick, et al.. (2020). Indole-3-lactic acid associated with Bifidobacterium-dominated microbiota significantly decreases inflammation in intestinal epithelial cells. BMC Microbiology. 20(1). 357–357. 192 indexed citations
11.
Merleev, Alexander A., Dayoung Park, Yixuan Xie, et al.. (2020). A site-specific map of the human plasma glycome and its age and gender-associated alterations. Scientific Reports. 10(1). 17505–17505. 15 indexed citations
12.
Xu, Gege, Haiping Zhao, Jingdong Xu, et al.. (2020). Hard antler extract inhibits invasion and epithelial–mesenchymal transition of triple-negative and Her-2+ breast cancer cells by attenuating nuclear factor-κB signaling. Journal of Ethnopharmacology. 269. 113705–113705. 14 indexed citations
13.
Ma, Xiaoyan, et al.. (2020). The DNA repair enzyme MUTYH potentiates cytotoxicity of the alkylating agent MNNG by interacting with abasic sites. Journal of Biological Chemistry. 295(11). 3692–3707. 10 indexed citations
14.
Goonatilleke, Elisha, Jincui Huang, Gege Xu, et al.. (2019). Human Milk Proteins and Their Glycosylation Exhibit Quantitative Dynamic Variations during Lactation. Journal of Nutrition. 149(8). 1317–1325. 46 indexed citations
15.
Bronner, Denise N., Franziska Faber, Erin E. Olsan, et al.. (2018). Genetic Ablation of Butyrate Utilization Attenuates Gastrointestinal Salmonella Disease. Cell Host & Microbe. 23(2). 266–273.e4. 59 indexed citations
16.
Xu, Gege, Dayoung Park, Stefanos Kalomoiris, et al.. (2018). FGF2 Induces Migration of Human Bone Marrow Stromal Cells by Increasing Core Fucosylations on N-Glycans of Integrins. Stem Cell Reports. 11(2). 325–333. 31 indexed citations
17.
Ng, Bobby G., Gege Xu, Deepali N. Shinde, et al.. (2018). Biallelic Mutations in FUT8 Cause a Congenital Disorder of Glycosylation with Defective Fucosylation. The American Journal of Human Genetics. 102(1). 188–195. 53 indexed citations
18.
Xu, Gege, Jasmine C. C. Davis, Elisha Goonatilleke, et al.. (2016). Absolute Quantitation of Human Milk Oligosaccharides Reveals Phenotypic Variations during Lactation. Journal of Nutrition. 147(1). 117–124. 135 indexed citations
19.
Rivera-Chávez, Fabian, Franziska Faber, Christopher A. Lopez, et al.. (2016). Depletion of Butyrate-Producing Clostridia from the Gut Microbiota Drives an Aerobic Luminal Expansion of Salmonella. Cell Host & Microbe. 19(4). 443–454. 608 indexed citations breakdown →
20.
Chang, Cuilan, Xianjiang Li, Yu Bai, et al.. (2013). Graphene matrix for signal enhancement in ambient plasma assisted laser desorption ionization mass spectrometry. Talanta. 114. 54–59. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026